Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose


Autoria(s): Christoph, Patricia; Schuller, Christine; Studer, Hanna; Irion, Olivier; De Tejada, Begoña Martinez; Surbek, Daniel
Data(s)

2012

Resumo

Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose. We aimed to assess side effects and tolerance of ferric carboxymaltose compared to i.v. iron sucrose in pregnant women.

Identificador

http://boris.unibe.ch/16475/1/jpm-2011-0231.pdf

Christoph, Patricia; Schuller, Christine; Studer, Hanna; Irion, Olivier; De Tejada, Begoña Martinez; Surbek, Daniel (2012). Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. Journal of perinatal medicine, 40(5), pp. 469-74. Berlin: De Gruyter 10.1515/jpm-2011-0231 <http://dx.doi.org/10.1515/jpm-2011-0231>

doi:10.7892/boris.16475

info:doi:10.1515/jpm-2011-0231

info:pmid:22945271

urn:issn:0300-5577

Idioma(s)

eng

Publicador

De Gruyter

Relação

http://boris.unibe.ch/16475/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Christoph, Patricia; Schuller, Christine; Studer, Hanna; Irion, Olivier; De Tejada, Begoña Martinez; Surbek, Daniel (2012). Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. Journal of perinatal medicine, 40(5), pp. 469-74. Berlin: De Gruyter 10.1515/jpm-2011-0231 <http://dx.doi.org/10.1515/jpm-2011-0231>

Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed

Formato

application/pdf